 |
Diabetic Neuropathies (Latest Articles)
Latest indexed articles for 'Diabetic Neuropathies'
Articles 111 to 120 of 200:
27 Feb 2009 
AIM: To identify the relationship between vascular endothelial growth factor (VEGF) and diabetic polyneuropathy (DPN). METHODS: Two hundred and twenty diabetic patients participated, 113 with DPN and 107 without DPN. All patients were also ...
rec_pub_19317819-serum-vegf-increases-diabetic-polyneuropathy-particularly.htm
27 Feb 2009 INTRODUCTION: A reliable and valid clinical tool to capture symptoms and signs of diabetic sensorimotor polyneuropathy (DSP) for use in clinical research trials is urgently needed. The validated Toronto Clinical Neuropathy Score (TCNS) was modified ...
rec_pub_19317818-reliability-validity-modified-toronto-clinical-neuropathy-score.htm
27 Feb 2009 AIMS: To compare gait parameters of older people with diabetes and no peripheral neuropathy (DM) and people with diabetes and diabetic peripheral neuropathy (DPN) and to investigate the effect of a secondary motor or cognitive task on their gait. ...
rec_pub_19317817-the-effect-cognitive-motor-task-gait-parameters-diabetic-patients.htm
27 Feb 2009 We evaluated the associations between glycemic therapies and prevalence of diabetic peripheral neuropathy (DPN) at baseline among participants in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial on medical and ...
rec_pub_19335534-prevalence-diabetic-peripheral-neuropathy-relation-glycemic-control.htm
Femoral nerve involvement in diabetics.
27 Feb 2009 BACKGROUND AND PURPOSE: In this study, the conduction of the femoral nerve has been evaluated in diabetic patients without clinical signs of femoral nerve involvement and in a group of healthy subjects. METHODS: Forty-eight patients have been ...
rec_pub_19364365-femoral-nerve-involvement-diabetics.htm
27 Feb 2009 PURPOSE: The influence of an irreversible inhibitor of constitutive NO synthase (L-NOArg; 1.0 mg/kg ip), a relatively selective inhibitor of inducible NO synthase (L-NIL; 1.0 mg/kg ip) and a relatively specific inhibitor of neuronal NO synthase ...
rec_pub_19300402-bradykinin-receptors-antagonists-nitric-oxide-synthase-inhibitors.htm
27 Feb 2009 OBJECTIVES: The present study was undertaken in order to verify the hypothesis stating that patients with depression exhibit some abnormalities concerning a cerebral symmetry. For this purpose, an analysis of the relationship between the VEPs ...
rec_pub_19300390-interhemispheric-cerebral-asymmetry-detected-veps-diabetic-patients.htm
27 Feb 2009 The aim of this study was the search of association of polymorphic markers T(-365)C of POLG1 gene, G(-25)A of ANT1 gene and G(-605)T of PEO1 gene with diabetic polyneuropathy (DPN) in type 1 diabetes mellitus (T1DM) patients. All patients were ...
rec_pub_19425506-association-t-365-c-polg1-g-25-ant1-g-605-t-peo1-gene-polymorphisms.htm
What are the common causes of facial neuropathy?
27 Feb 2009 
rec_pub_19278057-what-common-causes-facial-neuropathy.htm
Diagnosis and prevalence of onychomycosis in diabetic neuropathic patients: an observational study.
27 Feb 2009 BACKGROUND: An observational study was conducted to assess the prevalence of onychomycosis in clinically suspected diabetic neuropathic patients and to assess the reliability of the diagnosis. METHODS: One hundred successive type 1 and 2 diabetic ...
rec_pub_19299350-diagnosis-prevalence-onychomycosis-diabetic-neuropathic-patients.htm
Results: [1-10] [11-20] [21-30] [31-40] [41-50] [51-60] [61-70] [71-80] [81-90] [91-100] [101-110] [111-120] [121-130] [131-140] [141-150] [151-160] [161-170] [171-180] [181-190] [191-200]